Sacubitrilat (INN; or LBQ657) is the active metabolite of the antihypertensive drug sacubitril,[1] which is used in the treatment of heart failure.[2]

References

  1. ^ Solomon SD. "HFpEF in the Future: New Diagnostic Techniques and Treatments in the Pipeline". Boston. p. 48. Retrieved 2012-01-26.
  2. ^ "FDA approves new drug to treat heart failure". Food and Drug Administration. 7 July 2015.
Allikas: http://en.wikipedia.org/wiki/Sacubitrilat
No tags for this post.